Status:
COMPLETED
HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users
Lead Sponsor:
University of Maryland, Baltimore
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
HIV
Drug Use Disorders
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
HIV infected drug users have greater difficulty adhering to highly active antiretroviral therapy compared to non-drug users. As sustained adherence to highly active antiretroviral therapy is critical ...
Detailed Description
Significance: HIV infected drug users have greater difficulty adhering to HAART compared to non-drug users. As sustained adherence is critical to reducing HIV related morbidity and mortality, innovati...
Eligibility Criteria
Inclusion
- Diagnosis of HIV
- English speaking
- History of drug use in the last 6 months
- Able to carry a cell phone
- Able to read English
- Starting or switching to a new anti-retroviral medications
- Receiving care in a clinic participating in the study
Exclusion
- Clinical problems that would not allow someone to use a cell phone or fulfill study procedures.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01413529
Start Date
September 1 2011
End Date
April 1 2015
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jacques Initiative
Baltimore, Maryland, United States, 21210